companydata.dkcompanydata.dk

Nordic Liposomes ApS: Financial statements 2024

CVR: 43161725

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Nordic Liposomes ApS (CVR 43161725) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 100,194 and a net result of DKK 66,871 compared with DKK 67,655 the year before. That is a decrease of 3.8% compared with the year before. Equity in the 2024 report amounted to DKK 106,746. The solvency ratio was 19.2%.

Gross Profit
DKK 100,194
Profit/Loss
DKK 66,871
Equity
DKK 106,746
Total Assets
DKK 556,295
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-100K67K107K0
2023-104K68K40K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Nordic Liposomes ApS: The 2023 annual report is outJun 4, 2024

Nordic Liposomes ApS has published its annual report for 2023. Gross profit came to DKK 104,123, and the net result was DKK 67,655.

About Nordic Liposomes ApS

Nordic Liposomes ApS is a Danish company of the type Anpartsselskab based in Søndersø, founded in 2022. The company is registered under the industry Andre fremstillingsaktiviteter i.a.n.. The company was previously named Nordicliposomes ApS. The management consists of Morten Thvilum and Trine Albers Huusfeldt. The company is owned by CIRRUS HOLDING ApS and Huusfeldt ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 546,069 and a net result of DKK 336,862 compared with DKK 66,871 the year before. Equity in the 2025 report amounted to DKK 443,608.

Source: annual report 2025, Danish Business Authority

Other financial years